CG vs IVZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

CG

65.9
AI Score
VS
IVZ Wins

IVZ

68.9
AI Score

Investment Advisor Scores

CG

Oct 22, 2026
66score
Recommendation
STRONG BUY

IVZ

Oct 22, 2026
69score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CG IVZ Winner
Forward P/E 7.6336 9.5147 CG
PEG Ratio 0.6522 0.9008 CG
Revenue Growth -32.9% 20.5% IVZ
Earnings Growth -57.5% 35.0% IVZ
Tradestie Score 65.9/100 68.9/100 IVZ
Profit Margin 13.0% -0.9% CG
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation STRONG BUY HOLD CG

Relative Price Performance (Last 90 Days)

CG 1M: -1.8% · 3M: -13.7% IVZ 1M: -6.3% · 3M: -3.8%

Current Technical Phase

CG

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.7 · Price: $39.20

IVZ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.1%), weak momentum, RSI 41

RSI (14): 40.9 · Price: $28.79

Fundamentals Snapshot

Metric CG IVZ
Market Cap — —
Forward P/E 7.9 8.8
Trailing P/E 38.4 —
Revenue (TTM) — —
Revenue Growth -0.3% 0.2%
Gross Margin 1.0% 0.3%
Operating Margin 0.3% 0.2%
EPS 0.97 -0.68
Dividend Yield 0.04% 0.03%

Frequently Asked Questions

Based on our detailed analysis, IVZ is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.